Are These Stocks Valuable Low-Price Investments? Extreme Networks, Inc(NASDAQ:EXTR) and Bio-Path Holdings Inc(NASDAQ:BPTH)

Posted by admin August 18, 2014 0 Comment 822 views

New York, NY – 08/18/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

Extreme Networks, Inc(NASDAQ:EXTR) lost forty cents during Friday’s trading, a 7.48% decrease in value which left the stock at a closing price of $4.95. However, the stock regained sixteen cents during after-hours trading to move to a value of $5.11. While the new mark does offset a large proportion of the stock’s loss, the California-based network infrastructure equipment provider remains just $1.58 above its 52 week low of $3.53.

After the markets closed Thursday, Extreme Networks reported its fiscal fourth quarter financial results. The company recorded a GAAP net loss of $0.17 per share for the quarterly period and $0.60 for the fiscal year. According to the press release, this was the second quarter during which Extreme Networks reported figures that included its previous Enterasys acquisition.

Is Extreme Networks Undervalued? Receive A Free EXTR Analysis.

Bio-Path Holdings Inc(NASDAQ:BPTH) saw its value decline by seventeen cents during Friday’s trading, a 7.05% loss that left the stock at a closing price of $2.24. The stock, which traded within a range of $2.20 to $2.50 during the day after opening at the latter figure, remains $1.78 above and $3.01 below its 52 week low and high figures of $0.46 and $5.25, respectively. The Texas-based biotechnology company has a market capitalization of $217.98 million.

On Aug. 14th, Bio-Path Holdings, which was added to the Russell 3000® and Russel Microcap® indexes earlier during the summer, reported its quarterly results. The reported figures included an on-hand cash balance in excess of $15.7 million. Bio-Path expects its current business plan to cost $12.8 million over the next eighteen months.

Should You Make An Investment While Bio-Path Sits Close To The $2 Mark? View Our Free BPTH Analysis.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment